ORTINGLOBE

ORTIN GLOBAL LIMITEDNSE
₹15.93+0.49 (+3.17%)

Market Closed · NSE · INR

Open

₹16.2

High

₹16.2

Low

₹15.32

Prev Close

₹15.44

52-Week Range54% from low
₹11.19
₹19.92

Market Cap

₹12.55 Cr

Small Cap

P/E (TTM)

-

EPS

₹-1.12

Div Yield

-

P/B Ratio

10.47

ROE

-73.0%

Key Metrics

Forward P/E-
Book Value₹1.52
Debt/Equity0.81×
Revenue Growth-70.8%
Profit Margin-
Operating Margin-1000.00%
Volume57.5 K
Avg Volume (20d)12.6 K
Delivery %89.91%
Trades95

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascul...

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.